Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2)

Status:
Active, not recruiting

Trial end date:
2022-08-31

Target enrollment:

Participant gender:

This is a multi-center, randomized, double-blinded, placebo controlled trial.

Phase 3

Novartis Pharmaceuticals

Letrozole